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Purpose. The objective of this study was to evaluate nanoparticle
uptake by the Caco-2 monolayer model in vitro. Special emphasis was
placed on the localization and the quantification of the uptake of
fluorescently labeled polystyrene and poly(lactic-co-glycolic acid)
(PLGA) nanoparticles.
Methods. Intracellular fluorescence was localized by fluorescence and
confocal laser scanning microscopy. Particle uptake was quantified
either directly, by counting internalized nanoparticles after separa-
tion from the Caco-2 monolayers, or indirectly, by extraction of the
lipophilic fluorescence marker. In vitro release studies of lipophilic
markers from nanoparticles were performed in standard buffer sys-
tems and buffer systems supplemented with liposomes.
Results. Instead of uptake of polystyrene and PLGA nanoparticles by
Caco-2 monolayers an efficient transfer of lipophilic fluorescence
markers from nanoparticles into Caco-2 cells with subsequent stain-
ing of intracellular lipophilic compartments was observed. Whereas
in standard buffer no release of fluorescent marker from polystyrene
and PLGA nanoparticles was observed, the release studies using li-
posome dispersions as receiver revealed an efficient transfer of fluo-
rescent marker into the liposome dispersion.
Conclusions. The results suggest that the deceptive particle uptake is
caused by a collision-induced process facilitating the transfer of lipo-
philic fluorescent marker by formation of a complex between the
nanoparticles and the biomembranes. Diffusion of the marker within
this complex into lipophilic compartments of the cell strongly affects
quantitative evaluation of particle uptake.
KEY WORDS: nanoparticle; Caco-2 cells; particle uptake; fluores-
cence; drug release.
INTRODUCTION
Several handicaps and barriers limit the oral bioavailabil-
ity of drugs. Most relevant is the enzymatic metabolic barrier
resulting in modification or cleavage of orally administered
drugs and the physical barrier of the intestinal mucosa which
relates to the low permeability of the tight junctional com-
plexes in this epithelium. At the beginning of the last century
it was generally understood that drugs only passed the intes-
tinal epithelium when they were in a dissolved state. How-
ever, in 1906 Hirsch observed that in fact starch particles fed
to rats were also absorbed and, therefore, found in the intes-
tinal mucosa (1). Since the late nineteen fifties several authors
investigated various particulate polymeric carriers and came
up with the view that the particulate material itself, its particle
size and the encapsulated drug exert major effects on the rate
and extent of particulate uptake (2–6). The phenomena of
uptake and transport through the epithelium of the intestinal
tract are of the highest interest for the delivery of peptides,
proteins and vaccines. Beneficial usage of this process could
include the enhancement of drug absorption and bioavailabil-
ity; the targeting of therapeutic agents to particular intestinal
organs such as the gut associated lymphoid tissue (GALT) or
the development of antigen carriers to achieve improved an-
tigen presentation and mucosal immunity.
However, this field has not been without controversial
discussions about the involved mechanisms and the extent of
particle uptake by the intestine. Whereas Eldridge et al. (7)
demonstrated that particle uptake was mainly through the
Peyer’s patches, other authors observed the transmucosal
passage of particles to occur in the villous tissues adjacent to
Peyer’s patches or along the entire small intestine (8,9). The
physical properties of the particles such as size, surface charge
and hydrophobocity seemed to strongly influence their intes-
tinal uptake. Several authors have extensively reviewed this
subject (10–12).
The human colon adenocarcinoma cell line Caco-2 is a
well-established cell culture model to study the intestinal per-
meability of drugs (13). Confluent Caco-2 monolayers form
tight junctional complexes, exhibit dome formation and elec-
trical properties similar to those of the intestinal epithelium.
Previously several groups suggested the Caco-2 monolayers
to function as a suitable in vitro model to investigate particle
uptake into human intestine (12,14–16). Typically biodegrad-
able nano- or microparticles made of poly(lactic acid) (PLA),
or poly(lactic-co-glycolic acid) (PLGA) or non-biodegradable
poly(styrene) (PS) particles were used for this purpose. Par-
ticles were labeled by loading them with fluorescent marker
molecules like rhodamine B, fluorescein or coumarin-6 to
provide both visual and quantitative evidence for cellular up-
take and to avoid the problems associated with the use of
radioactive materials.
However, fluorescence markers have been shown to
cause experimental problems. For instance, Suh et al. (17)
observed that marker molecules loaded into the matrix of
particles or adsorbed to the particle surface during the prepa-
ration process might leak or dissociate from the particle. This
may compromise the interpretation of particulate uptake
data.
The objective of this study was to evaluate nanoparticle
uptake by Caco-2 monolayers and their cellular localization.
Biodegradable PLGA nanoparticles loaded with fluorescent
markers and commercially available non-biodegradable poly-
styrene nanoparticles were used. Intracellular fluorescence
was localized by fluorescence microscopy and confocal laser
scanning microscopy (CLSM). Particle uptake was analyzed
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by the quantification of extracted nanoparticles and by ex-
traction of the fluorescence marker from the particles. Ex-
periments were performed using viable and non-viable cell
monolayers. Special attention was given to the effect of po-
tential marker release from the nanoparticles. In vitro release
studies in the presence of liposomes were used as a tool to
evaluate the transfer of highly hydrophobic markers upon
physical contacts between nanoparticles and the lipid bilay-
ers. In this context we will evaluate the potential of collision-
induced transfer of lipophilic markers from the nanoparticles
into into Caco-2 monolayers as a mechanism to mimic the
uptake of particulate matter.
MATERIALS AND METHODS
Chemicals
Polystyrene nanoparticle suspension (Fluoresbrite Plain
YG, mean diameter 0.5 m, particle concentration 2.69%,
w/w) was purchased from Polysciences Inc. (Warrington PA,
USA), poly-(DL-lactic-co-glycolic acid) (Resomer 752) was
obtained from Boehringer-Ingelheim (Ingelheim, Germany).
Nile red was from Aldrich Chemie (Buchs, Switzerland), cou-
marin 6 was from Acros Organics (Geel, Belgium). Polyvinyl
alcohol 15’000 from Fluka Chemie AG (Buchs, Switzerland)
was used as emulsion stabilizer. Oregon green phalloidin, rho-
damin phalloidin and Hoechst 33342 were from Molecular
Probes (Leiden, Netherlands). Epikuron 145 V was a gift
from Lucas Meyer GmbH (Hamburg, Germany). All other
chemicals were supplied by Fluka (Buchs, Switzerland) and
were of chemical grade. If not otherwise specified cell culture
media were supplied from Gibco, Life Technologies AG
(Basel, Switzerland).
PLGA Nanoparticle Preparation
PLGA nanoparticles were prepared by using a modified
oil-in-water solvent evaporation method according to (18).
Briefly, 500 mg PLGA was dissolved in 10 ml methylene chlo-
ride, and 0.1% nile red or coumarin 6 were added. The solu-
tion was poured into 50 ml cold water containing 0.2% PVA
as emulsifier. The emulsion was homogenized on ice for 5 min
by ultrasonication (Vibra Cell, Sonics & Materials, Newtown
Connecticut) and transferred into a reaction vessel. The sol-
vent was evaporated using reduced pressure under constant
stirring. After 3 h the nanoparticles were purified using gel
filtration as described by Beck et al. (19). The gel filtration
medium was Sephadex G 50 medium (Amersham Pharmacia
Biotech, Uppsala, Sweden). The nanoparticles were freeze
dried after separation of free marker and stored at 4°C.
Nanoparticle Characterization
Particle diameters were analyzed by field emission scan-
ning electron microscopy (Hitachi S-700, Tokyo, Japan) after
drying in a critical point dryer using CO2 as the transitional
solvent and by photon correlation spectroscopy (Nicomp 370,
Particle Sizing Systems, Santa Barbara California). Nanopar-
ticles were visualized by fluorescence microscopy (Axiovert
35, Zeiss AG, Zurich, Switzerland).
Cell Culture
Caco-2 cells (passage 72 and 76) were a gift from the
Institute of Physiology of the University of Zurich, Switzer-
land. They were seeded at a density of 25,000 cells/cm2 on
glass cover slides or in tissue culture treated 6-wells (diameter
3.6 cm, Techno Plastic-Products AG, Trasadingen, Switzer-
land) and grown in an atmosphere of 5% CO2, using Dulbec-
co’s modified Eagle’s Medium with Glutamax-I, sodium py-
ruvate and 4.5 g/L glucose. The medium was supplemented
with 16.5% fetal calf serum and 0.1 mM nonessential amino
acids. Cells were grown for 14 to 16 days and medium was
changed every other day.
Particle Uptake Studies
Polystyrene and PLGA nanoparticles were suspended in
transport buffer (TB) containing 1 mM CaCl2, 3 mM KCl, 1
mM MgCl2, 135 mM NaCl, 1 mM NaH2PO4 and 5 mM D-
glucose at a concentration of 100 g/ml for polystyrene and 10
mg/ml for PLGA nanoparticles. The pH was adjusted to 6.8
with 25 mM HEPES. Prior to selected experiments cells were
fixed with ice cold 3% paraformaldehyde in phosphate buff-
ered saline (PBS; 2.7 mM KCl, 1.5 mM KH2PO4, 135 mM
NaCl and 8 mM Na2HPO4 adjusted to pH 7.4) for 30 m.
Nanoparticle suspensions were prewarmed to 37°C and added
to the cell monolayer. Monolayers were incubated for 60 min
and washed twice with TB and three times with PBS.
The viability of the cell monolayers was checked using a
live/dead kit (Molecular Probes, Leiden, The Netherlands)
after incubation for 30 min with a solution of 4 M ethidium
homodimer-1 and 2 M calcein AM in PBS. Samples were
cautiously rinsed with fresh PBS and analyzed by fluorescent
microscopy.
Microscopy
Caco-2 monolayers were fixed and stained with Hoechst
33342 (nuclei) and rhodamine (red fluorescence) or oregon
green (green fluorescence) phalloidin (F-actin) depending on
the respective marker of the nanoparticles and mounted in
Lisbeth’s imbedding medium. The samples were analyzed
with either light and fluorescent microscopy (Axiovert 35,
Zeiss AG, Zurich, Switzerland) or confocal laser scanning
microscopy (CLSM) (LSM 410, Zeiss AG, Zurich, Switzer-
land) equipped with an Ar UV excitation laser (excitation 363
nm), an Ar excitation laser (excitation 488 nm) and a HeNe
excitation laser (excitation 543 nm) within 24 h. Images were
processed on a Silicon Graphics workstation using IMARIS,
a 3D multichannel image processing software for confocal
microscopic images (Bitplane AG, Zurich, Switzerland).
Quantification of Nanoparticle Uptake
After particle incubation the Caco-2 monolayers were
washed four times with TB and three times with PBS. Then 2
ml of distilled water were added to each well and the cells
were homogenized within the well using ultrasonication (Vi-
bra Cell, Sonics & Materials, Newtown Connecticut).
The number of particles taken up by Caco-2 monolayers
after 30 m was determined by counting the fluorescent nano-
particles using a hemocytometer. Polystyrene and PLGA
nanoparticle concentration in the incubation medium was de-
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termined by the same method prior to the experiment. Re-
sults were expressed as percentage of number of particles
found in the homogenate as compared to the total number of
nanoparticles applied to the cells. For marker quantification
the cell homogenate was freeze-dried. Methylene chloride
was used to extract the marker from the freeze-dried residue.
Quantification of the marker was performed by fluorimetry
(Fluoromax, Spex Instruments, Middlesex, England). Control
experiments confirmed a fluorescent marker recovery of over
95%.
Statistics
Each result is presented as mean ± SD with n  3. Sta-
tistical significance was tested on the basis of Student’s t test
at 95% confidence intervals.
Release Studies
To study the transfer of fluorescence markers from nano-
particles to liposomes as a simplified lipid bilayer model, a
liposomal dispersion was prepared by dissolving 0.5 mmol
Epikuron 145V and 0.25 mmol cholesterol in a mixture of
methylene chloride and methanol (2:1) in a round bottomed
flask. The lipid film was dried in a rotary evaporator and
hydrated with 43 ml TB for 30 min. Sonication on ice for 10
m resulted in liposomes with a mean diameter of 50–80 nm.
The in vitro release of fluorescence markers from PLGA
nanoparticles and fluorescence labeled polystyrene nanopar-
ticles in TB and in the liposomal dispersion was performed in
two different experimental set-ups. Firstly, nanoparticles
were dispersed in 2 ml prewarmed TB or in the liposomal
dispersion and incubated at 37°C in rotating 4-ml-vials (Chro-
macol, London, UK) Samples were taken at regular time in-
tervals and centrifuged. The supernatant was filtered through
a 0.2 m regenerated cellulose filter (Schleicher & Schuell,
Dassel, Germany) to remove any residual particles, and
freeze-dried. The resulting residue was extracted with meth-
ylene chloride and analyzed by fluorimetry as described
above.
Secondly, to avoid direct contacts between the nanopar-
ticles and the liposomes, an equilibrium dialysis set-up
(Macro 2 equilibrium dialysis cells, Dianorm, Munich, Ger-
many) was used with 2.0 ml nanoparticle dispersion in the
donor and 2.0 ml liposomal dispersion in the receiver. A pre-
conditioned dialysis membrane with a molecular weight cut-
off of 10 kDa (Dianorm, Munich, Germany) separated the
two chambers. The dialysis cells were slightly rotated at 37°C.
Samples were taken at regular intervals and further processed
as described above.
RESULTS
Electron microscopy of PLGA and polystyrene nanopar-
ticles revealed their regular, spherical shape (Fig. 1). Gener-
ally, their surface morphology was smooth, without any vis-
ible pinholes or cracks. Although coumarin-6 labeled nano-
particles appear slightly smaller (Fig. 2 middle), the size
distribution of all particles was unimodal with diameters in
the total range of 300–600 nm and a mean diameter of 400–
500 nm as confirmed by photon correlation spectroscopy. The
encapsulation efficiency of nile red and coumarin-6 in PLGA
nanoparticles after gel permeation chromatography was 70–
80% of the theoretical content. The nominal load of the par-
ticles was 0.1 % (w/w).
After 60 m incubation uptake of polystyrene nanopar-
ticles into Caco-2 cells was very poor as shown by confocal
laser scanning microscopy (CLSM). Typically, polystyrene
particles were attached to the apical cell surface only (Fig. 2).
No particles could be observed intracellularly or at the baso-
lateral side. However, a highly fluorescent punctated pattern
indicating spherical structures of up to 2 m diameter was
visible in the cells (Fig. 3), preferentially at the basolateral
side. Note that nanoparticle diameters were generally smaller
than 700 nm. Moreover, background fluorescence of the cells
was significantly increased and, vs. controls without nanopar-
ticles, intracellular structures became increasingly apparent
(Fig. 4). Without nanoparticles background fluorescence was
negligible. The observations were independent of particle
type and fluorescence marker used. Similar results were al-
ready obtained after 30 min of incubation.
To rule out that the spherical structures represent nano-
particle agglomerates, nile red and coumarin-6 loaded PLGA
nanoparticles were applied simultaneously. Fluorescence mi-
croscopy images using selective red respectively green filters
demonstrated that red and green fluorescence were strictly
colocalized (Fig. 5). An overlay of the images showed perfect
congruence of the two patterns. This excludes that the ob-
served fluorescent spheres represent single nanoparticles or
nanoparticle agglomerates. Actual uptake of nanoparticles
would have resulted in locally variable red and green staining
instead of perfect uniformity of the pattern. As control the
experiment was also performed with paraformaldehyde fixed,
non-viable cells to exclude active uptake processes, e.g. by
phagocytosis. As before green and red fluorescence was
clearly colocalized, irrespective of the viability status of the
samples.
Quantitative evaluation of particle uptake was per-
formed by counting the number of nanoparticles extracted
from cell monolayers. Within 30 m less than 1% of the totally
administered polystyrene nanoparticles was adsorbed on the
cells or found in the cells (Table I). When the nanoparticles
were coated with human serum albumin or -globuline their
interaction with the interface of the Caco-2 monolayer was
significantly reduced. These findings were in strong contrast
to the results obtained by analyzing the amount of fluores-
cence marker extracted from the cells. Up to 10% of the
fluorescent markers from polystyrene nanoparticles were
found in the cell monolayers (Fig. 6). Cell homogenates were
found to be visually free of PLGA nanoparticles, but up to
7% of fluorescence marker were extracted from the cells.
The quantitative analysis of nanoparticle uptake into
Fig. 1. SEM of nile red (left) and coumarin-6 (middle) labeled PLGA
and labeled polystyrene nanoparticles (right panel). Spherical par-
ticles with a smooth surface and diameters in the total range of 300–
600 nm and a mean diameter of 400–500 nm were obtained.
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Caco-2 cells was repeated with paraformaldehyde-fixed, non-
viable cells. Interestingly, there was no significant difference
between the uptake of marker into viable and non-viable cells
independent of the carrier material and the type of fluores-
cence marker used (Fig. 6). These findings exclude relevant
particle uptake by Caco-2 monolayers involving active
mechanisms, e.g. by phagocytosis, which would be exclusive
for viable cells. Instead of active nanoparticle uptake, we pro-
pose passive transfer of the marker partitioning of the hydro-
phobic markers from the nanoparticles into lipophilic cell
compartments such as lipid membranes and vesicles.
To further confirm this mechanism we studied the in
vitro release of the marker from PLGA and polystyrene
nanoparticles into TB (Fig. 7). Overall marker release was
low. After 3 h marker release from PLGA nanoparticles was
slightly higher ∼1%) than from polystyrene nanoparticles
(<0.5%). This may be explained by traces of polyvinyl alcohol
used as emulsion stabilizer during PLGA nanoparticle prepa-
ration.
The release studies of fluorescent nanoparticle disper-
sions in the donor chamber and liposome dispersion in the
receiver chamber led to a linear release of the marker into the
liposome compartment (Fig. 7). Polystyrene nanoparticles re-
leased about 1% marker after 60 m and 3.5% after 3 h,
whereas PLGA particles released about 5% after 60 m and up
to 50% after 3 h. Marker release was strongly enhanced when
the nanoparticles were in direct contact with the liposome
dispersion without the dialysis membrane in between. After
60 m about 5% of the marker from polystyrene particles and
more than 50% of the PLGA markers were found to be trans-
ferred into the liposomes. After 60 m the release rates were
approximately linear in both systems. No further release of
markers was observed after 2 h.
Fig. 2. CLSM of Caco-2 monolayer after incubation with polystyrene
nanoparticles for 60 min (red). Typically, particles were only attached
to the apical cell surface (arrowheads). Green: F-actin; blue: nuclei.
Fig. 3. CLSM image of Caco-2 cells incubated with PLGA nanopar-
ticles for 60 min. Arrows indicate spherical structures (yellow) at the
basolateral side of the cells. The size distribution of the structures
indicates that they are bigger than the PLGA-nanoparticles (arrow-
heads). Green: F-actin; Blue: nuclei.
Fig. 4. Picture of Caco-2 cells before (a) and after (b) incubation with
nile red loaded PLGA nanoparticles for 60 min. Spherical structures,
probably intracellular lipid droplets, as well as the strongly increased
background fluorescence are visible by fluorescence microscopy
(Zeiss Axiovert 35).
Fig. 5. Fluorescence microscopy of Caco-2 monolayers after simultaneous incubation with nile red and coumarin-6 labeled
PLGA nanoparticles for 60 min. a red filter; b green filter; c overlay of a and b. Fluorescence in a and b is strictly colocalized.
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DISCUSSION
In order to study particle uptake in vivo or in vitro, the
use of fluorescently or radioactively labeled particles is the
most common experimental approach found in the literature.
We preferred fluorescent labeling because of easier handling.
Thereby, particle uptake by cells becomes readily detectable
by fluorescence microscopy or CLSM and the extent of par-
ticle uptake may be determined directly by flow cytometry or
indirectly by quantitative extraction of the marker from the
cells.
Because its structural and functional differentiation is
similar to mature enterocytes, the Caco-2 monolayer model is
an established in vitro tool to evaluate the intestinal perme-
ability and metabolism of drugs (13). Reasonable correlations
could be established between in vivo data and data obtained
in Caco-2 monolayers (20). With respect to nanoparticles,
Desai et al. demonstrated that uptake into Caco-2 cells was
influenced by various parameters such as particle size and
incubation time. An uptake efficiency of up to 41% was cal-
culated after extracting the fluorescent marker from cell
monolayers (14). In contrast, using CLSM, McClean et al. (16)
reported that upon particle uptake in Caco-2 cells, the frac-
tion of intracellularly detected particles was insignificant as
compared to the number of particles totally administered. In
the present study, using PLGA nanoparticles with loadings of
highly hydrophobic fluorescent markers and commercially
available polystyrene nanoparticles, we were unable to dem-
onstrate significant particle uptake into or transport through
Caco-2 cell monolayers by CLSM. According to our observa-
tions, the particles were only attached to the apical surface of
the cells but not internalized. Successful internalization of
particles was very rare. However, highly fluorescent, spherical
structures in the cells raised questions about their nature and
composition.
The contradictory findings in the quantitative uptake be-
tween the number of particles found in the cell homogenate
and the amount of marker extracted from cells were obvious.
The experimental results with a mixture of differently labeled
PLGA nanoparticles applied on the Caco-2 monlayers indi-
cate that the intracellular spherical structures were not single
nanoparticles or nanoparticle aggregates. In addition, there
was no visually detectable difference between Caco-2 mono-
layers incubated with fluorescent marker loaded particles or
with an aqueous suspension of the pure marker alone (results
not shown). Moreover, the equivalent amount of fluorescence
marker extracted from both viable and non-viable (cross-
linked with paraformaldehyde) monolayers led us to the con-
clusion that the transfer of hydrophobic fluorescent markers
into Caco-2 cells occurred without the involvement of particle
uptake.
Greenspan et al. (21) reported nile red to be a powerful
stain to visualize lipophilic cytoplasmatic components of fixed
or viable macrophages and smooth muscle cells by fluores-
cence microscopy, e.g. intracellular lipid droplets. The au-
thors concluded that highly lipophilic dyes could be used to
Table I. Polystyrene (PS) Nanoparticles of Various Types Counted
in Caco-2 Cells after 30 Minutes Incubation
Type of particle
Number of
PS particles
Uptake*
[%]
PS, uncoated 2.29 ± 0.33 × 107 0.8
PS, coated with human serum albumin 5.83 ± 0.26 × 106 0.2
PS, coated with -globuline 5.90 ± 0.16 × 106 0.2
* Numbers include both adsorbed and internalized particles.
Fig. 7. Fluorescent marker release from polystyrene (Fig. 7a) and
PLGA (Fig. 7b) nanoparticles into different receiver compartments:
() TB separated from the nanoparticle suspension by a dialysis
membrane, () TB supplemented with liposomes separated from the
nanoparticle suspension by a dialysis membrane, and () TB supple-
mented with liposomes in direct contact (without a dialysis mem-
brane) with the nanoparticle suspension.
Fig. 6. Marker uptake from polystyrene (NP PS), nile red labeled
PLGA (PLGA NR) and coumarin 6 labeled PLGA (PLGA C6)
nanoparticles. No significant differences in marker uptake into viable
(light grey) and non-viable (dark grey) Caco-2 monolayers were ob-
served.
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stain cell membranes and intracellular lipophilic domains. Ac-
cording to Haynes and Cho (22) the transfer of lipophilic
markers from particles into cells can occur through several
processes: (i) exclusively by phagocytosis; (ii) by sequential
dissociation of the marker from the particles, convective dif-
fusion of the free marker into the medium and its subsequent
partitioning into cells; and (iii) by a collision-induced non-
phagocytic process entailing partitioning of a fraction of the
entrapped substance directly from the surface of donor par-
ticles into the receiving cells.
Phagocytosis, an exclusive feature of viable cells, could
be ruled out for our investigation. This was clearly demon-
strated by equivalent intracellular staining patterns observed
in both viable and non-viable cells. Therefore in accordance
with our release studies we suggest that the diffusion process
and the collision-induced process are responsible for the
transfer of the marker into the cells. The possibility of direct
contacts between the particles and the cell membrane seems
to accelerate the transfer of the markers. Our release experi-
ments demonstrated that in TB without liposomes only mar-
ginal marker release rates were detected. This was also ex-
pected from the low water solubility of the lipophilic markers.
In the dialysis set-up with liposome dispersion in the receiver,
marker release was increased. Linear release kinetics was ob-
served. Only when the marker-loaded nanoparticles were in
physical contact with the liposomal dispersion rapid transfer
rates of the marker were observed. Therefore, we conclude
from our results that direct transfer of the marker from the
nanoparticles to the membrane leads to the staining of the cell
wall and subsequently of the lipophilic domains of the cell.
Previously, Mutsch et al. (23) postulated a lipid exchange
mechanism involving collisional contacts to give rise to rapid
exchange of lipids differing widely in chemical nature be-
tween liposomes and brush border vesicles. The exchange
occurs by diffusion within the collisional complex formed be-
tween the liposome and brush border vesicles. Diffusion is
considered to be a fast process (24) so that the collision rate
is rate limiting rather than the diffusion of the molecules
within the collision complex. Similarly, a collision model was
postulated for a nile red oil-in-water emulsion (22). It was
suggested that the transfer of nile red from various emulsions
to macrophages may occurred via a collision-induced mecha-
nism. By analogy we suggest that the transfer of lipophilic
markers from nanoparticles into the liposomes is collision-
induced and elicits substantial and immediate transfer of the
lipophilic marker into the membrane, followed by a slower
diffusion controlled process. We propose that the same
mechanism applies for the uptake of lipophilic markers into
Caco-2 monolayers, mimicking particulate matter uptake.
Therefore, we suppose that active particle uptake by endocy-
tosis by Caco-2 monolayers is probably the result of artefacts
caused by the transfer of lipophilic markers from nanopar-
ticles into lipophilic cell compartments. However, as a conse-
quence, the same mechanism may offer new strategies for the
efficient delivery of drugs with poor aqueous solubility and
high lipophilicity to cells of the mammalian body.
Although we employed liposomes to clarify the mecha-
nism of marker exchange on membrane interfaces, these ex-
periments do not linearly compare with the quantitative
marker uptake in cell monolayers. Liposomes represent a
very simplified model for mimicking cells. Confluent cellular
monolayers contain a larger variety of acceptor compart-
ments, such as the cytosol, intracellular organelles and inter-
cellular spaces that may also be of different volume as com-
pared to liposomes. Thus, differences in hydrophilicity of the
marker used in the PLGA particles and polystyrene particles
may result in a different distribution behavior of cells vs.
liposomes. In addition, the chemical nature of the fluorescent
marker incorporated into the commercial polystyrene nano-
particles is not clear due to proprietary reasons. No informa-
tion is available from the manufacturer whether the fluores-
cent label is covalently linked or just incorporated into the
polystyrene nanoparticles. Anyway, our data strongly suggest
that at least a significant portion of the label is not covalently
bound to the polymer but sufficiently free to allow its imme-
diate transfer to cells or lipid bilayer structures.
In summary, our study demonstrates that polystyrene
and PLGA nanoparticles were not taken up by Caco-2 mono-
layers. Instead we observed an efficient transfer of lipophilic
fluorescence markers from nanoparticles into Caco-2 cells
with subsequent staining of intracellular lipophilic compart-
ments and thereby mimicking particle uptake into the cell
monolayers. Whereas in vitro release studies using standard
PBS buffer systems showed no release of lipophilic fluores-
cent marker from polystyrene and PLGA nanoparticles, fur-
ther in-vitro release studies using liposome dispersions as re-
ceiver revealed an efficient transfer of fluorescent marker
into the liposome dispersion. The results suggest that the de-
ceptive particle uptake is caused by a collision-induced pro-
cess facilitating the transfer of lipophilic fluorescent marker
by formation of a complex between the nanoparticles and the
biomembranes of the Caco-2 cells or the liposomes, followed
by a diffusion of the marker within this complex according to
the concentration gradient. Consequently, the extent of trans-
fer of lipophilic markers from nanoparticles is facilitated by a
collision-induced process therefore affecting quantitative
evaluation of particle uptake. In conclusion, our study ques-
tions previous nanoparticle uptake studies into Caco-2 cell
monolayers and intestinal epithelium based on nanoparticles
with non-covalently linked lipophilic markers.
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